Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.73 -0.37 (-0.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Total Liabilities (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International's Total Liabilities came in at $241.96 million for Q2 2026, up 45.6% from $166.14 million a year earlier and up 10.2% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Total Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Kiniksa Pharmaceuticals International's Total Liabilities was $196.03 million, up 37.9% from FY2024.

  • Total Liabilities has increased in each of the last six years, with a five-year compound annual growth rate of 39.2% (FY2020 to FY2025).
  • Going back by year, Total Liabilities was $142.12 million in FY2024 (+62.5%), $87.48 million in FY2023 (+37.7%), $63.52 million in FY2022 (+33.0%) and $47.76 million in FY2021 (+27.3%).
  • The Q2 2026 figure represents the highest quarterly Total Liabilities in data going back to Q4 2017.
  • Year-over-year, Total Liabilities has increased for 13 consecutive quarters, with growth averaging 52.3% over the last eight quarters.
  • The fastest year-over-year change in Total Liabilities over five years came in Q3 2022 (growth of 95.7%), and the weakest in Q1 2023 (a decline of 18.5%).
  • Business Quant data shows KNSA's Total Liabilities at $219.59 million (Q1 2026), $196.03 million (Q4 2025) and $176.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Kiniksa Pharmaceuticals International 11.87 Bn 10.61 Bn 220.03 Mn 241.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 241.96 Mn
Mar 31, 2026 219.59 Mn
Dec 31, 2025 196.03 Mn
Sep 30, 2025 176.95 Mn
Jun 30, 2025 166.14 Mn
Mar 31, 2025 141.84 Mn
Dec 31, 2024 142.12 Mn
Sep 30, 2024 118.29 Mn
Jun 30, 2024 107.33 Mn
Mar 31, 2024 87.78 Mn
Dec 31, 2023 87.48 Mn
Sep 30, 2023 77.94 Mn
Jun 30, 2023 72.68 Mn
Mar 31, 2023 52.77 Mn
Dec 31, 2022 63.52 Mn
Sep 30, 2022 75.95 Mn
Jun 30, 2022 57.08 Mn
Mar 31, 2022 64.72 Mn
Dec 31, 2021 47.76 Mn
Sep 30, 2021 38.81 Mn
API Access

Kiniksa Pharmaceuticals International Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=KNSA&period=max&api_key=YOUR_API_KEY